Ameliora Wealth Management’s Precision BioSciences DTIL Stock Holding History

Ameliora Wealth Management’s Portfolio DTIL Stock Details DTIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-33	Closed	-$139	–	228
2025 Q2	$139	Hold	33	–	–	﹤0.01%	214
2025 Q1	$157	Hold	33	–	–	﹤0.01%	238
2024 Q4	$126	Hold	33	–	–	﹤0.01%	237
2024 Q3	$296	Hold	33	–	–	﹤0.01%	162
2024 Q2	$321	Hold	33	–	–	﹤0.01%	182
2024 Q1	$447	Hold	33	–	–	﹤0.01%	194
2023 Q4	$365	Hold	33	–	–	﹤0.01%	183
2023 Q3	$341	Hold	33	–	–	﹤0.01%	214
2023 Q2	$526	Hold	33	–	–	﹤0.01%	193
2023 Q1	$754	Hold	33	–	–	﹤0.01%	213
2022 Q4	$1.19K	Hold	33	–	–	﹤0.01%	222
2022 Q3	$1K	Buy	+33	New	+$1.57K	﹤0.01%	219

Other funds holding DTIL

Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

LCM

Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Ameliora Wealth Management's DTIL Position: Q3 2025 in Review

Ameliora Wealth Management sold out of Precision BioSciences (DTIL) in Q3 2025, closing a stake of 33 shares — an estimated $139 sold.

Ameliora Wealth Management first reported a position in DTIL in Q3 2022 and held it in 12 quarters. The position peaked at $1.19K in Q4 2022. 56 funds tracked by Wall St. Rank hold DTIL as of Q3 2025.

Ameliora Wealth Management reported no remaining Precision BioSciences position as of Q3 2025 after selling out during the quarter.
Ameliora Wealth Management sold 33 Precision BioSciences shares in Q3 2025, an estimated $139.
Ameliora Wealth Management first reported a position in Precision BioSciences in Q3 2022 and held it in 12 quarters.
Ameliora Wealth Management's Precision BioSciences position peaked at $1.19K in Q4 2022.
56 funds tracked by Wall St. Rank held Precision BioSciences as of Q3 2025.

Based on Ameliora Wealth Management's 13F filing for Q3 2025, filed 12 Nov 2025.